Stocks and Investing Stocks and Investing
Thu, September 12, 2024
[ 12:00 AM ] - WOPRAI
Michael Brown Initiated (BX) at Buy and Held Target at $163 on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
Andrew Charles Reiterated (BROS) at Strong Buy and Held Target at $47 on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
John Massocca Maintained (BRT) at Strong Buy and Held Target at $21 on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
Michael Brown Initiated (BRDG) at Buy and Held Target at $11 on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
Thomas Poutrieux Upgraded (BILL) to Buy and Held Target at $90 on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
George Staphos Maintained (BCC) at Sell with Increased Target to $124 on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
Patrick Moley Reiterated (BGC) at Buy and Held Target at $12 on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
Michael Brown Initiated (BEN) at Hold and Held Target at $20 on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
Yi Chen Reiterated (BLTE) at Strong Buy and Held Target at $60 on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
Michael Brown Initiated (BLK) at Buy on, Sep 12th, 2024
[ 12:00 AM ] - WOPRAI
Debjit Chattopadhyay Initiated (BNTC) at Strong Buy and Held Target at $17 on, Sep 12th, 2024
Wed, September 11, 2024
[ 12:00 AM ] - WOPRAI
Scott Graham Initiated (BMI) at Strong Buy and Held Target at $235 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Sohrab Movahedi Maintained (BN) at Buy with Increased Target to $50 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Kristen Owen Maintained (BIOX) at Buy with Decreased Target to $16 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Ben Klieve Maintained (BIOX) at Strong Buy with Decreased Target to $13 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Scott Fortune Maintained (BIOX) at Strong Buy with Decreased Target to $13 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Austin Moeller Maintained (BIOX) at Strong Buy with Decreased Target to $13 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Benjamin Gerlinger Maintained (BKU) at Hold with Decreased Target to $39 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (BFAM) at Sell with Increased Target to $100 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Benjamin Burnett Maintained (BEAM) at Strong Buy with Increased Target to $69 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Emily Bodnar Reiterated (BCTX) at Strong Buy and Held Target at $18 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
John Lawrence Reiterated (BOOT) at Strong Buy and Held Target at $140 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Blaine Heck Maintained (BXP) at Buy with Increased Target to $80 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Nicholas Yulico Maintained (BXP) at Buy with Increased Target to $82 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Geoff Meacham Maintained (BBIO) at Strong Buy and Held Target at $42 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Sohrab Movahedi Maintained (BAM) at Hold with Increased Target to $40 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Hans Engel Upgraded (AZN) to Strong Buy on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Betty Jiang Maintained (APA) at Hold and Held Target at $35 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (ANF) at Buy and Held Target at $190 on, Sep 11th, 2024
[ 12:00 AM ] - WOPRAI
Gregory Fraser Downgraded (ANIP) to Hold and Decreased Target to $60 on, Sep 11th, 2024

Gregory Fraser Downgraded (ANIP) to Hold and Decreased Target to $60 on, Sep 11th, 2024


Published on 2024-10-28 14:12:29 - WOPRAI, Gregory Fraser
  Print publication without navigation


Gregory Fraser of Truist Securities, Downgraded "ANI Pharmaceuticals, Inc." (ANIP) to Hold and Decreased Target from $80 to $60 on, Sep 11th, 2024.

Gregory has made no other calls on ANIP in the last 4 months.



There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, 0 agree with Gregory's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gregory

  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $94 on, Wednesday, August 7th, 2024
Contributing Sources